Jack O’Meara

Jack O’Meara is co-founder and CEO of Ochre Bio. Ochre develops genomic medicines that rejuvenate transplanted livers, and ultimately hopes to treat fatty liver disease (NASH/NAFL) and other metabolic diseases. Ochre employs spatial sequencing, advanced genomics, and high-throughput screening to identify disease-causing genes and develops combination therapies which are tested in donor livers kept alive outside of the body. Jack is a biomedical engineer by training, with a background in bringing new healthcare innovations to market. His career spans management consulting, company creation, health technology and biopharma market launches. He has a BEng from National University of Ireland, Galway, and MSc from the University of Notre Dame.